Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Aparna R. Parikh(Massachusetts General Hospital), Ryan B. Corcoran(Massachusetts General Hospital), Dora Dias‐Santagata(Harvard University), Bezaye Teshome(Massachusetts General Hospital), Jaime L. Schneider(Harvard University), Colin D. Weekes(Massachusetts General Hospital), Heather A. Shahzade(Harvard University), Giulia Siravegna(University of Turin), Theodore S. Hong(Massachusetts General Hospital), Katie Kanter(Massachusetts General Hospital), A. John Iafrate(Massachusetts General Hospital), Madeleine G. Fish(Massachusetts General Hospital), Lipika Goyal(Stanford Medicine), Emily E. Van Seventer(Massachusetts General Hospital), Jochen K. Lennerz(Addgene), David P. Ryan(East Carolina University), Nora Horick(Massachusetts General Hospital), Jennifer Y. Wo(Massachusetts General Hospital), Kathryn Fosbenner(Massachusetts General Hospital), Lawrence S. Blaszkowsky(Brigham and Women's Hospital), Bruce J. Giantonio(Northwestern University), Isobel J. Fetter(Harvard University), Jeffrey W. Clark(Massachusetts General Hospital), Andrew X. Zhu(Icahn School of Medicine at Mount Sinai), Brandon Nadres(Massachusetts General Hospital), Ashraf Thabet(Harvard University), Amikasra Mojtahed(Harvard University), Ryan David Nipp(Harvard University), Jill N. Allen(Harvard University), Eric Roeland(Harvard University)
Cited by 143
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
|Nature Biotechnology|2014|2.3k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k